Skip to main content

Table 2 Results in each therapy with prostate cancer patients

From: Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX score

Number (%) or median (Mean ± SD)

Variables

Total (1220)

Brachy Tx (547)

Prostatectomy (200)

EBRT (267)

Hormonal monotherapy (187)

Age

74 (73.3 ± 7.1)

73 (72.1 ± 6.4)

72.5 (72.1 ± 7.1)

75 (74.6 ± 6.5)

77 (76.3 ± 8.2)

Weight (kg)

64 (64.3 ± 8.9)

64 (64.6 ± 8.7)

63.6 (63.7 ± 8.3)

65 (65.1 ± 9.2)

63 (63.3 ± 9.9)

Height (cm)

165 (165.5 ± 6.0)

165 (165.7 ± 6.1)

165 (165.4 ± 5.8)

166 (165.7 ± 5.9)

165 (164.6 ± 6.0)

Previous fracture

255 (20.9 %)

111 (20.2 %)

40 (20.0 %)

63 (23.6 %)

35 (18.7 %)

Parent Fractured Hip

90 (7.4 %)

38 (6.9 %)

19 (8.5 %)

18 (6.7 %)

12 (6.4 %)

Current Smoking

138 (11.3 %)

71 (13.0 %)

26 (13.0 %)

22 (8.2 %)

16 (8.6 %)

Glucocorticoid

38 (3.1 %)

3 (0.5 %)

4 (2.0 %)

8 (3.0 %)

19 (10.2 %)

Rheumatoid arthritis

13 (1.1 %)

3 (0.5 %)

3 (1.5 %)

3 (1.1 %)

4 (2.1 %)

Secondary osteoporosis

108 (8.9 %)

45 (8.2 %)

20 (10.0 %)

26 (9.7 %)

18 (9.6 %)

Alcohol 3 or more units per day

380 (31.1 %)

174 (31.8 %)

72 (36.0 %)

95 (35.6 %)

38 (20.3 %)